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Introduction
Adolescence requires some risk-taking as independence from the 
family is taking form, but for some teens, risk taking may lead to 
unhealthy or unsafe decisions. Risky behaviors such as unprotected 
sex, reckless driving, and substance use are associated with lasting 
negative outcomes (e.g. Cavazos-Rehg et al., 2011). With regard to 
substance use, the annual Monitoring the Future study reported that 
marijuana is the most commonly used illicit drug in the United 
States, with 7% of 12th graders reporting daily use (Johnston et al., 
2013). Individuals who engage in regular substance use may have a 
higher propensity to take unsafe risks (such as the decision to use 
recreational drugs regularly) despite the possible negative conse-
quences (e.g. Lejuez et al., 2002; Schuster et al., 2012). Without 
testing adolescents prior to initiation of substance use, it is difficult 
to determine whether elevated levels of risk-taking predated sub-
stance use. However, risk-taking performances of adolescents with 
and without histories of regular marijuana use can help us to under-
stand what leads some individuals to substance-related problems.
The Balloon Analogue Risk Task (BART; Lejuez et al., 2002) 
offers a behavioral assessment of risk-taking. In adult samples, 
riskier BART performance has been associated with higher levels 
of alcohol use (Fernie et al., 2010; Weafer et al., 2011) as well as 
substance use, gambling, unsafe sex, and stealing (Lejuez et al., 
2002), and it has successfully differentiated MDMA ((+/-) 
3,4-methylenedioxymethamphetamine; “ecstasy”) users from 
controls (Hopko et al., 2006). Riskier BART performance was 
also associated with greater alcohol, cigarette, and polydrug use 
in a community sample of young adults (Lejuez et al., 2002). 
Among adolescents, riskier BART performance was related to 
greater self-reported substance use and safety risk behaviors 
(Aklin et al., 2005; Lejuez et al., 2003, 2007). Adolescent patients 
with conduct disorder and co-morbid substance abuse/depend-
ence have also shown greater risk-taking with the BART com-
pared to healthy controls (Crowley et al., 2006).
Some studies have examined marijuana users specifically. For 
example, adolescent marijuana users demonstrated impulsive 
decision-making (i.e. poor reflection impulsivity) with the 
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Information Sampling Test (Solowij et al., 2012); however, users 
had a median of less than 24 h of abstinence. Using the BART, 
Schuster et al. (2012) found that riskier BART performance was 
correlated with higher levels of risky sexual behavior among 
young adult marijuana users; however, participants may have 
used marijuana the day prior to testing and were not compared to 
non-users. Gonzalez et al. (2012) found no differences on the 
BART in a sample of young adult marijuana users versus non-
using controls; however, Gonzales et al. allowed for recent mari-
juana use (>24 h), with a median of three days since past use. 
Because previous studies of young marijuana users allowed for 
recent use, the effects of residual marijuana levels may have 
affected task performance. In the current study, we examined 
risk-taking via the BART in late adolescent marijuana users with 
at least two weeks of abstinence from marijuana, in comparison 
to non-using controls. This approach (a) considers how mari-
juana users function relative to their non-using peers and (b) 
reduces possible residual effects from recent substance use. We 
hypothesized that participants reporting greater substance use 
would demonstrate riskier BART performance.
Further, previous studies have not yet examined the relation-
ship of risk-taking to executive functioning in adolescent mari-
juana users. Executive function is a complex collection of 
abilities (e.g. planning and decision-making, flexibility of think-
ing, working memory, verbal fluency, as well as impulse control 
and reward processing) primarily modulated by the prefrontal 
cortex. Several studies have found altered prefrontal cortex pro-
cessing and executive dysfunction in marijuana users (e.g. Jager 
et al., 2010; Schweinsburg et al., 2008; Tapert et al., 2007). 
Completing the BART has also been linked to increased prefron-
tal cortex activation in healthy controls (Rao et al., 2008), and a 
recent meta-analysis of neuroimaging studies suggested that 
individuals with substance use disorders may have altered risk 
processing compared to healthy controls, primarily in ventrome-
dial prefrontal cortex, orbitofrontal cortex, striatum, and other 
areas involved in risk and decision-making (Gowin et al., 2013). 
Given the involvement of the prefrontal cortex in both risk-tak-
ing and executive functioning, we examined whether elevated 
risk-taking, as measured by the BART, was associated with 
poorer executive functioning, as measured by traditional neu-
ropsychological tests. We hypothesized that a riskier approach to 
the BART would be associated with poorer performance on 
executive function tests.
Methods and materials
Participants
Participants were part of a longitudinal study of marijuana’s 
effects on neurocognition during adolescence and young adult-
hood, with assessments at intake (ages 15–18) and at 18- and 
36-month follow-ups (e.g. Hanson et al., 2010; Medina et al., 
2007; Schweinsburg et al., 2008). Adolescents were recruited 
from local high schools. Teens and their parents/guardians were 
screened for demographics, psychosocial functioning, and family 
history of Diagnostic and Statistical Manual for Mental 
Disorders, 4th Ed. (DSM-IV; American Psychiatric Association 
(APA), 2000) substance use and other Axis I disorders. 
Confidentiality was ensured within legal limits to encourage full 
disclosure. Prior to participation, written informed assent 
(adolescents) and consent (adults and parent/guardians) were 
obtained in accordance with the University of California, San 
Diego Human Research Protections Program. At study intake, 
exclusionary criteria included history of psychiatric disorder 
other than substance use disorder, serious medical problem or 
head trauma, premature birth, prenatal drug or alcohol exposure, 
and substance use during monitored abstinence. Intake classifica-
tion criteria (Medina et al., 2007) for the marijuana-user group 
included >60 lifetime marijuana experiences; past month mari-
juana use; <100 lifetime uses (<10 in past three months) of drugs 
other than marijuana, alcohol, or nicotine; and not meeting 
Cahalan criteria for heavy drinking status (Cahalan et al., 1969). 
To produce an adequate sample size, controls were included if 
they had <5 lifetime experiences with marijuana (none in the past 
month), no previous use of any other drug except nicotine or 
alcohol, and did not meet criteria for heavy drinking status.
The current data were collected at the 18-month follow-up, 
when participants were aged 17–20 years. A total of 48 marijuana 
users and 52 controls completed the BART task at the 18-month 
follow-up; however, 24 marijuana users and 18 controls were 
excluded from analyses based on the following abstinence 
requirements: at least two weeks since last use of marijuana, 
other drugs, or alcohol binge (to reduce residual effects of such 
use and allow for removal from the body; excluded n=23 mari-
juana users, n=11 controls); and at least three days since last use 
of any alcohol or psychiatric medications (n=2 additional con-
trols). Beyond the abstinence requirements, follow-up controls 
were further excluded for meeting abuse or dependence criteria 
for alcohol or any other substance (n=4 additional controls). One 
participant in the baseline marijuana group had no marijuana 
uses in the previous 18 months and was also excluded, and one 
additional control was excluded due to meeting DSM-IV criteria 
for current post-traumatic stress disorder.
Following these exclusions, the resulting sample of 58 demo-
graphically matched adolescents and young adults (ages 17–20; 
29% female; 60% Caucasian; see Table 1) included 24 marijuana 
users and 34 non-using controls. At the 18-month follow-up, 
marijuana users were about seven months older (p<0.05), and as 
expected, reported higher levels of marijuana, alcohol, and other 
drug use than controls. marijuana users had 200+ lifetime mari-
juana use episodes and <130 lifetime experiences with other 
drugs. In addition, 10 marijuana users met DSM-IV criteria for 
marijuana abuse and seven for marijuana dependence (one for 
past dependence), 10 met criteria for alcohol abuse, and two met 
criteria for other drug abuse. At the 18-month follow-up, the 34 
controls had ≤15 lifetime experiences with marijuana, minimal to 
no previous other drug use except nicotine or alcohol (three con-
trols had 1–2 past drug uses).
Measures
Screening interview. A structured clinical interview measured 
psychosocial functioning, health history, and family history of 
psychiatric and substance use disorders (Rice et al., 1995). Prob-
able DSM-IV Axis I disorders were determined by the computer-
ized Diagnostic Interview Schedule for Children Predictive 
Scales (Lucas et al., 2001; Shaffer et al., 2000). Adult participants 
living independently completed corresponding modules of the 
computerized Diagnostic Interview Schedule (C-DIS-IV; Robins 
et al., 1996).
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Parent interview. A parent/guardian was interviewed on child 
development and behavior, and youth/family medical and psy-
chiatric history (Rice et al., 1995). Parents/guardians corrobo-
rated youth diagnostic reports with the parent version of the 
Diagnostic Interview Schedule for Children Predictive Scales. If 
participant self-report and parent collateral data were discrepant, 
additional information was reviewed from the file, and data were 
coded to reflect the presence of the symptom, to reduce partici-
pant and researcher bias.
Substance use. Participants were administered the Customary 
Drinking and Drug Use Record to evaluate their lifetime, past 
three-month, and past 18-month use of nicotine, alcohol, mari-
juana, stimulants (cocaine, amphetamines, MDMA/ecstasy), hal-
lucinogens, inhalants, opiates (heroin, narcotic pain medications), 
dissociatives (phencyclidine, ketamine), sedatives (gamma-
hydroxybutyric acid, barbiturates, benzodiazepines), and abuse 
of over-the-counter or prescription medications. Teens were also 
assessed for alcohol and drug withdrawal symptoms, related life 
problems, and DSM-IV abuse and dependence criteria (Brown 
et al., 1998; Stewart and Brown, 1995). The Timeline Follow-
back (Sobell and Sobell, 1992) facilitated recall of substance use 
over the past 28 days through a calendar layout.
BART. The BART is a computer-based risk-taking assessment 
(Lejuez et al., 2002). Participants used the space bar to pump 30 
simulated balloons one at a time to achieve the highest possible 
score. Balloons pop at an unpredictable rate (possible range: 
1–128 pumps; average=64 pumps), and a noise follows each 
response (popping, or coins falling for a “save” response). The 
points earned for a balloon are lost if it pops, but temporary 
points can be saved by choosing “Save Points.” Participants 
weigh the increasing risk of popping each balloon (and losing 
points) against the potential gain of continuing to pump the bal-
loon (to accrue points and gain a reward). The primary outcome 
measures were the mean number of pumps for balloons that did 
not pop (average adjusted pumps) and the total number of popped 
balloons during the session. High values on either variable sug-
gest greater risk taking. The number of points earned on any bal-
loon and the total points saved are not revealed to the participant 
– only whether they had earned a small, medium, big, or bonus 
prize (i.e. various sizes of candy) depending on the amount of 
points saved. They were shown the possible candy rewards prior 
to starting the task and received the reward immediately upon 
completion of the task. Participants had no practice trials to 
assess risk, and each participant completed the same task (i.e. the 
balloons and the destiny pop points of the balloons were exactly 
the same, and occurred in the same order, for each participant). 
This measure has good test-retest reliability (r =0.77; White 
et al., 2008).
Mood and personality. Mood and personality were measured 
to help characterize the sample and examine whether elevations 
in depressive, anxiety, or internalizing/externalizing symptoms 
were related to BART performance. Mood and anxiety were 
assessed using the Beck Depression Inventory (BDI; Beck, 1978) 
and the Spielberger State-Trait Anxiety Inventory (STAI; Spiel-
berger et al., 1970). We used the Child Behavior Checklist 
(CBCL) Youth Self-Report and Adult Self-Report (Achenbach 
and Rescorla, 2001) to measure internalizing and externalizing 
behaviors.
Neuropsychological testing. General intellectual ability was 
assessed by the Vocabulary (at project intake) and Block Design 
subtests of the Wechsler Abbreviated Scale of Intelligence 
(WASI; Wechsler, 1999). Measures of executive function 
included the Digit Span task (number of digits recalled in for-
ward and backward sequence) from the Wechsler Adult Intelli-
gence Scale-Third Edition (WAIS-III; Wechsler, 1997); and the 
Trail Making, Towers, and Verbal Fluency tests from the Delis-
Kaplan Executive Functioning System (D-KEFS; Delis et al., 
2001).
Procedures
Participants were abstinent from marijuana, other drugs, and 
alcohol binge for at least two weeks prior to the assessment, veri-
fied with biweekly breathalyzer tests and urine screens (Quest 
Diagnostics) including at the neuropsychological testing session. 
The urine screen tested for major substances including ampheta-
mines, barbiturates, benzodiazepines, cocaine metabolites, mari-
juana metabolites, and opiates. Exclusions for recent substance 
Table 1. Demographic and substance use information for participants.
Controls (n=34) M (SD) Marijuana users (n=24) M (SD)
Agea 18.9 (0.9) 19.5 (0.9)
CBCL Externalizing T-scorea 48.4 (6.7) 52.1 (7.7)
Age regular (weekly) marijuana use began – 15.8 (1.8)
Lifetime marijuana use episodesb 2.0 (3.7) 771.9 (488.3)
Marijuana use days, past 18 monthsb 1.4 (3.5) 252.7 (196.0)
Days since last marijuana use at NP testing sessionb 623.5 (584.8)c 52.9 (52.7)
Lifetime alcohol use episodesb 46.9 (65.3) 430.3 (338.7)
Occasions drunk, past 18 monthsb 7.2 (12.9) 71.7 (93.7)
Lifetime other drug use episodesb 0.1 (0.4) 28.8 (32.9)
Other drug use days, past 18 monthsb 0.03 (0.2) 18.9 (26.4)
NP: neuropsychological; SD: standard deviation; CBCL: Child Behavior Checklist Youth Self-Report and Adult Self-Report (Achenbach and Rescorla, 2001).
ap<0.05; bp<0.001.
cIncludes only controls who have used marijuana in their lifetime (n=13).
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use are described above in the section on participants. All partici-
pants completed questionnaires and the neuropsychological bat-
tery. Teens and their parents/guardians received monetary 
compensation upon study completion.
Statistical analysis
We used Fisher’s Exact Tests to compare categorical variables 
between groups and analysis of variance (ANOVA) to examine 
group differences on continuous variables. Some alcohol and 
drug use variables did not meet requirements for parametric anal-
ysis; therefore we used the Mann-Whitney procedure to compare 
these characteristics between groups. Because marijuana users 
were slightly older than controls, age was controlled in analyses 
of test performance using univariate analysis of covariance 
(ANCOVA). Effect sizes are presented as partial eta-squared (ηp2, 
range: 0–1), and interpretations of statistical significance were 
made if p<0.05. We used Pearson correlations to examine asso-
ciations between risk-taking, demographic, and neuropsycho-
logical variables. As an exploratory analysis, we performed 
hierarchical multiple regressions to examine whether BART per-
formance predicted past 18-month substance use, as described 
below. Distributions of substance use variables were examined 
and appropriately log10 transformed to meet the assumptions of 
parametric analysis.
Results
BART
Marijuana users had more popped balloons (F(1,55)=6.49, 
p=0.014, ηp2=0.11) than controls, over and above the effects of 
age (see Table 2). This was particularly notable on the first 
(F(1,55)=8.99, p=0.004, ηp2=0.14) and second set of 10 balloons 
(F(1,55)=4.03, p=0.05, ηp2=0.07); the group difference on the 
third set did not reach our criteria for significance (F(1,55)=1.70, 
p=0.20, ηp2=0.03) (see Figure 1). Groups did not differ on aver-
age adjusted pumps (F(1,55)=1.50, p=0.23, ηp2=0.03), therefore 
we did not further explore this variable.
Neuropsychological testing
Marijuana users performed worse than controls on D-KEFS Trail 
Making Number Letter Switching (i.e. visuomotor set-shifting; 
F(1,55)=4.19, p=0.046, ηp2=0.07), above and beyond effects of 
age (see Table 2). Groups did not differ on other measures of 
executive function (D-KEFS Towers or Verbal Fluency, WAIS-
III Digit Span Backward), attention/processing speed (WAIS-III 
Table 2. Balloon Analogue Risk Task (BART: Lejuez et al., 2002) and other neuropsychological test results.
Controls (n=34) M (SD) Marijuana users (n=24) M (SD)
BART
Average adjusted pumps 37.2 (11.5) 39.7 (11.4)
Popped balloonsa 9.1 (2.8) 10.8 (3.0)
General intellectual ability
WASI Vocabulary T-Score 58.2 (8.8) 59.0 (7.0)
WASI Block Design T-Score 60.6 (5.8) 59.3 (6.0)
Measures of executive functions
WAIS-III Digit Span Backward (raw score) 7.9 (2.3) 7.0 (1.5)
D-KEFS Trail Making: Number-Letter Switching SSa 11.7 (1.6) 11.1 (1.9)
D-KEFS Towers: Total Achievement SS 11.3 (2.4) 11.5 (2.6)
D-KEFS Verbal Fluency: Letter Fluency SS 13.0 (3.2) 13.3 (2.9)
Measures of attention and processing speed
WAIS-III Digit Span Forward (raw score) 11.4 (2.4) 10.6 (1.6)
D-KEFS Trail Making: Number Sequencing SS 12.3 (1.8) 12.4 (1.8)
D-KEFS Trail Making: Letter Sequencing SS 12.6 (1.7) 12.5 (1.5)
D-KEFS: Delis-Kaplan Executive Functioning System (Delis et al., 2001); SD: standard deviation; SS: scaled score; WAIS-III: Wechsler Adult Intelligence Scale-Third Edition 
(Wechsler, 1997); WASI: Wechsler Abbreviated Scale of Intelligence (Wechsler, 1999).
ap<0.05.
Figure 1. Adolescent marijuana (MJ) users (n=24) had more popped 
balloons on the Balloon Analog Risk Task (BART) relative to non-using 
controls (n=34) (overall: p<0.05), particularly on blocks 1 and 2. Each 
block included 10 trials. Error bars depict standard errors. *p≤0.05; 
**p<0.01.
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Digit Span forward, D-KEFS Trail Making: Number Sequencing 
and Letter Sequencing), or intelligence (WASI Vocabulary or 
Block Design; high average range overall).
Self-report mood and behavior
Marijuana users scored higher than non-using controls on CBCL 
externalizing behaviors (F(1,55)=4.66, p=0.035, ηp2=0.08) (see 
Table 1), after accounting for age. Groups did not differ on the 
BDI, STAI, or CBCL Internalizing scales.
Correlations
BART risk-taking and neuropsychological performance. The 
number of popped balloons was positively correlated with 
D-KEFS Trail Making Letter Sequencing (i.e. psychomotor pro-
cessing speed) scaled score (i.e. more popped balloons = better 
sequencing; r=0.30, p=0.02). The number of popped balloons did 
not correlate with measures of intelligence or executive function. 
To examine the effects of age and group, we computed partial 
correlations controlling for age and group membership, and the 
correlation of popped balloons with Letter Sequencing remained 
significant. BART performance was not associated with self-
reported depression, anxiety, or internalizing/externalizing 
behavior, demographic variables, or age.
Regressions
We used a series of exploratory hierarchical multiple regressions 
to examine whether BART performance predicted past 18-month 
substance use in the whole sample. We entered age in Block 1, 
and the number of popped balloons in Block 2. The log10 trans-
formed dependent variables were (a) past 18-month marijuana 
use episodes, (b) other drug use episodes, or (c) number of times 
drunk. Controlling for age, the equation using BART popped bal-
loons to predict past 18-month marijuana use was significant: 
Block 2, F(2, 55)=4.86, p=0.016; R2Δ=5.3%. Specifically, higher 
age was positively associated with marijuana use (β=0.32, 
p=0.015); having popped more balloons was associated with 
more marijuana use in the past 18 months but did not reach our 
criteria for statistical significance (β=0.23, p=0.072). BART per-
formance also predicted other drug use episodes over the past 18 
months above and beyond age, with the number of popped bal-
loons emerging as the strongest predictor: Block 2, F(2, 55)=3.70, 
p=0.031; R2Δ=9.1% (popped balloons: β=0.30, p=0.021; age: 
β=0.194, p=0.133). Having more popped balloons was not pre-
dictive of the number of times drunk in the past 18 months. If all 
three substance use variables were entered simultaneously to pre-
dict the number of popped balloons, the finding was not signifi-
cant. The above regression models were no longer significant 
when examining marijuana users alone.
Discussion
This study examined risk taking via the BART in late adolescents 
with or without a history of marijuana use. As hypothesized, par-
ticipants reporting greater substance use evidenced riskier BART 
performance. Specifically, marijuana users with at least two 
weeks of abstinence from marijuana, other drugs, or alcohol 
binge (verified by biological measurement) popped more bal-
loons than non-using controls throughout the task, especially in 
the first 20 (out of 30) balloons. Although speculative, it appears 
that the marijuana users started the task with a higher level of risk 
taking. After receiving feedback about their performance (in the 
form of popped balloons), they attempted to modify their 
approach to avoid popping balloons. The controls may have 
taken a similar approach, as illustrated in Figure 1; however, the 
marijuana users remained slightly more “risky” in their approach 
throughout the test.
Notably, the groups did not significantly differ in average 
adjusted pumps, which is the most commonly used variable for 
this task. Importantly, Pleskac et al. (2008) have suggested that 
the average adjusted pumps score may be biased and an underes-
timate of risky responses because it excludes the trials in which 
the balloon popped, as explained further below. For this reason, 
the number of popped balloons may be a more sensitive measure 
of risk-taking. Importantly, the groups were matched on self-
reported levels of depressive, anxiety, and internalizing symp-
toms; marijuana users scored higher on externalizing behavior, as 
expected. BART performance was not associated with these self-
reported mood and personality characteristics or demographic 
variables including age. This suggests that group differences in 
risk taking may be due to marijuana or other substance use, rather 
than other personal characteristics.
Previous studies have found mixed results. Consistent with 
the current study, some found that alcohol and other substance 
use was related to riskier BART performance (Fernie et al., 2010; 
Hopko et al., 2006; Weafer et al., 2011); however, others did not 
find group differences between non-using controls and at-risk/
addicted individuals or recently abstinent marijuana users using 
the BART average adjusted pumps variable (Gonzalez et al., 
2012; Meda et al., 2009). Further, BART performance did not 
relate to cannabis use disorder symptoms in Gonzalez et al., 
2012. Our study is consistent with Meda et al. (2009) and 
Gonzalez et al. (2012) with regard to finding no group difference 
on average adjusted pumps; however, the previous studies did not 
examine group differences in the number of popped balloons.
We also found that having a riskier BART performance (i.e. 
more popped balloons) significantly predicted a higher number 
of other drug use episodes in the past 18 months, above and 
beyond the effects of age. The equation using popped balloons 
to predict past 18-month marijuana use was also significant, but 
higher age was a stronger predictor than popped balloons. 
Having a riskier BART performance did not predict recent alco-
hol use. In other words, it appears that BART performance was 
associated with other drug use but not alcohol or marijuana use 
when also considering age. However, that result did not remain 
significant when controls were removed from the analysis. The 
BART may therefore have had relatively low sensitivity for 
measuring additional risk among regular marijuana users in this 
sample. Future studies could explore whether BART perfor-
mance is a useful predictor of additional risk above and beyond 
alcohol and marijuana use.
In addition to elevated BART risk-taking, abstinent mari-
juana users performed worse than controls on one aspect of 
executive functioning measured, consistent with previous stud-
ies reporting deficient executive skills or abnormal brain activa-
tion among marijuana users in this and other samples (e.g. 
Hanson et al. 1085
Hanson et al., 2010; Medina et al., 2007; Pope and Yurgelun-
Todd, 1996; Schweinsburg et al., 2008). Specifically, marijuana 
users exhibited poorer visuomotor set-shifting relative to non-
using controls. This suggests that young, abstinent marijuana 
users may have a mild weakness in cognitive flexibility in the 
context of changing task demands. Nevertheless, it is not clear 
if the average group difference on this task is clinically mean-
ingful, and marijuana users did not differ from controls on other 
aspects of executive skills including working memory, verbal 
fluency, and planning. Although not correlated with putative 
measures of executive function, riskier BART performance was 
associated with faster psychomotor sequencing speed. It is pos-
sible that a faster rate of responding may produce more popped 
balloons, or as speculation, risky behavior without adequate 
forethought may result in losses. This may concur with Solowij 
et al. (2012) who reported that marijuana using adolescents 
demonstrated “reflection impulsivity,” having faster response 
times even when uncertain and making more errors. Vigil-Colet 
(2007) also found that BART performance was most strongly 
related to “functional impulsivity,” a style in which decisions 
are made quickly and impulsively under certain beneficial cir-
cumstances. On the other hand, Meda et al. (2009) used princi-
pal components analysis to show that risk-taking (as measured 
by BART average adjusted pumps) may be distinct from other 
measures of the multidimensional construct of impulsivity (e.g. 
behavioral activation, self-reported impulsivity, reward or pun-
ishment sensitivity). Therefore the relationship between a faster 
processing speed, impulsivity, and risk-taking is not entirely 
clear and warrants additional study.
Overall, the BART appears to measure distinct aspects of 
risk-taking that have been associated with real-world behavior 
(e.g. substance use), suggesting it is a useful tool for assessing 
risk-taking in adolescents and young adults. Since the BART 
(popped balloons) was not correlated with established tests of 
executive functioning, this suggests that it is measuring a behav-
ior distinct from executive function, or at least distinct from the 
present tests of executive functions. Given the constellation of 
elevated risk-taking and inferior executive functioning, mari-
juana using teens may be at greater risk than non-users for anti-
social and safety risk behaviors, thus increasing the possibility of 
negative personal, social, legal, or occupational consequences 
(e.g. Aklin et al., 2005; Lejuez et al., 2003).
Limitations and future directions
One limitation of the present study was that, given the intercor-
relations between various substances of abuse, it was not possible 
to determine whether elevated risk-taking is a direct consequence 
of marijuana or any other substance use. Further, elevated risk-
taking may predate substance use. However, one might speculate 
that substance use exacerbates a premorbid tendency toward risk-
taking, placing the user at greater risk for harmful consequences 
(e.g. Ersche et al., 2013). Because we studied a community sam-
ple of marijuana users (and not those seeking clinical treatment), 
the differences between the non-using controls and marijuana 
users may be attenuated relative to clinical samples of marijuana 
users. We also acknowledge that, given the number of compari-
sons made, the risk of type-I error is increased. Given the sample 
size, we were not able to examine the presence of gender differ-
ences, and this is an area for future research.
In addition, we used a food reward (various sizes of candy) 
because the participants started the study when they were less 
than 18 years old, and we had to adjust reimbursement for study 
participation to protect this initially underage sample from pos-
sible coercion. Although Gonzalez et al. (2012), as well as the 
originators of the BART task (i.e. Lejuez et al., 2002) used mon-
etary rewards for BART performance (5 cents per pump), the cur-
rent sample had a higher average number of pumps (by about five 
pumps in the non-users and 7–9 pumps in the marijuana users), 
suggesting that a food reward was a sufficient motivator in this 
sample.
This study used a version of the BART that required manual 
pumps for each balloon (i.e. tap spacebar desired number of 
times) and did not provide feedback after each trial (e.g. explo-
sion point for previous balloon, amount earned). According to 
Pleskac et al., (2008) this manual BART may be biased due to 
psychomotor demands (tapping/processing speed). They further 
explained that the average adjusted pumps score is biased because 
it excludes responses that ended in an explosion (popped bal-
loon); therefore, it is an underestimate of the number of pumps 
the participant would have completed if the balloon had not 
popped. Given that we are examining the risky behavior that 
would lead to increased pumps and popped balloons, the average 
adjusted pumps may not be the optimal estimate of risky behav-
ior. This may partially explain why marijuana users and non-
using controls did not differ on this score. A newer automatic 
BART avoids biases by informing participants of the optimal 
number of pumps (i.e. 64 out of a possible 128), allowing them to 
numerically input pumps (i.e. typing in the desired number (e.g. 
85), rather than tapping the spacebar 85 times), and providing 
trial-by-trial feedback (e.g. “explosion point for last balloon = 
122,” amount earned, and balloon number; for further explana-
tion see Pleskac et al., 2008). Future studies should consider the 
automated BART to maximize behavioral variability. 
Additionally, we excluded recent users (less than two weeks of 
abstinence) to reduce residual effects of substance use; however, 
it is possible that cannabis users who did not complete the absti-
nence protocol may have produced a different pattern of results. 
Thus, risk-taking behavior may be examined over the first few 
weeks of abstinence to determine how behavior changes when 
substance use is stopped. We were not able to examine the precise 
role of various substances on BART performance; therefore, the 
role of alcohol and other drug use in risk-taking should be further 
explored. Future studies may also examine physiological meas-
ures of marijuana levels prior to and throughout the abstinence 
period. Given that self-reported externalizing behavior was not 
correlated with BART performance, we did not pursue this vari-
able further; however, future studies may consider the role of 
externalizing behavior on risk-taking and BART performance.
Implications
Marijuana and other substance use during adolescence and young 
adulthood is concerning because this is a critical time of continu-
ing brain development (Gogtay et al., 2004; Gogtay and 
Thompson, 2010). The primary structure involved in executive 
functions and impulse control (i.e., the prefrontal cortex) is one 
of the last cortical structures to mature (Gogtay et al., 2004). A 
review by Gowin et al. (2013) suggests that individuals with sub-
stance use disorders show alterations in the prefrontal cortex and 
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in adjacent areas involved in executive functions and risk/reward 
processing (e.g. the ventromedial prefrontal cortex, orbital fron-
tal cortex, dorsolateral prefrontal cortex, striatum, amygdala, 
anterior cingulate cortex, insular cortex), and these alterations 
have been associated with greater risk-taking on behavioral 
measures and elevated levels of substance use. Our finding of 
elevated risk-taking among marijuana users is in agreement with 
their hypothesis that substance users have impaired risk process-
ing that may result from underactivation of areas responsible for 
evaluating risks and/or an overactivation of reward processing 
centers (Gowin et al., 2013). Marijuana users’ poorer executive 
function (set-switching, or cognitive flexibility), while not cor-
related with the current measure of risk-taking, may reflect a 
weakness in flexibility of thinking that could also lead to defi-
ciencies in effectively integrating and organizing information.
In their review of prefrontal cortex function and addiction, 
George and Koob (2010) described the prefrontal cortex as highly 
modulated with a variety of subsystems, and a dysfunction of any 
of these subsystems could explain the individual differences in 
self-regulation and vulnerabilities to substance use and/or addic-
tion. Consistent with Romer et al. (2011), our findings also suggest 
that risk-taking is not always associated with executive dysfunc-
tion, and that there may not always be a linear relationship between 
the various executive cognitive functions (e.g. as tested by tradi-
tional neuropsychological measures) and more emotionally driven 
risk or reward processing. In light of the current and previous find-
ings, clinicians should consider that dysfunction within one or 
more prefrontal executive subsystems may be responsible for 
behavior leading to or resulting from problematic substance use, 
and that risk-taking may not necessarily imply deficient executive 
functioning. While some risk-taking in adolescence is important as 
youth evolve into independent adults, continued research on the 
neurobehavioral mechanisms for maladaptive risk-taking can help 
us to understand why some youth progress to regular substance use 
or develop substance use disorders.
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